?:authorAffiliation
|
-
[\'Canada\'s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.\', \'School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.\', \'BC Cancer Research Centre, BC Cancer, Vancouver, British Columbia, Canada.\', \'British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.\', \'Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Provincial Laboratory Medicine Services, Provincial Health Services Authority, Vancouver, British Columbia, Canada.\', \'British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.\', \'School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.\', \'Canada\'s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Canada\'s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada; Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: hirstm@mail.ubc.ca.\']
|